biotech / news / / Fortune
The analysis includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters.
White House analysis estimates $733 billion in potential prescription drug savings over a decade.
KEY POINTS
- Few details of Trump's deals with 17 major pharmaceutical companies have been publicly disclosed.
- Democrats argue the savings could be offset by higher costs for drugs not covered by the policy.
- Sen. Sanders’ staff analysis found drug company profits rose 66% since agreeing to Trump's plan.
- Trump administration claims projected savings are based on actual patient prices, not list prices.
COMPANIES
Summarized by Newsio from Fortune. How we summarize →